219 related articles for article (PubMed ID: 25273566)
1. Silencing KRAS overexpression in arsenic-transformed prostate epithelial and stem cells partially mitigates malignant phenotype.
Ngalame NN; Tokar EJ; Person RJ; Waalkes MP
Toxicol Sci; 2014 Dec; 142(2):489-96. PubMed ID: 25273566
[TBL] [Abstract][Full Text] [Related]
2. Aberrant microRNA expression likely controls RAS oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic.
Ngalame NN; Tokar EJ; Person RJ; Xu Y; Waalkes MP
Toxicol Sci; 2014 Apr; 138(2):268-77. PubMed ID: 24431212
[TBL] [Abstract][Full Text] [Related]
3. Silencing KRAS Overexpression in Cadmium-Transformed Prostate Epithelial Cells Mitigates Malignant Phenotype.
Ngalame NN; Waalkes MP; Tokar EJ
Chem Res Toxicol; 2016 Sep; 29(9):1458-67. PubMed ID: 27510461
[TBL] [Abstract][Full Text] [Related]
4. Arsenic Alters Exosome Quantity and Cargo to Mediate Stem Cell Recruitment Into a Cancer Stem Cell-Like Phenotype.
Ngalame NNO; Luz AL; Makia N; Tokar EJ
Toxicol Sci; 2018 Sep; 165(1):40-49. PubMed ID: 30169766
[TBL] [Abstract][Full Text] [Related]
5. Human prostate epithelial cells and prostate-derived stem cells malignantly transformed in vitro with sodium arsenite show impaired Toll like receptor -3 (TLR3)-associated anti-tumor pathway.
Alvarado-Morales I; Olivares-Illana V; Arenas-Huertero C; Reynaga-Hernández E; Layseca-Espinosa E; Tokar EJ; Escudero-Lourdes C
Toxicol Lett; 2021 Oct; 350():185-193. PubMed ID: 34303791
[TBL] [Abstract][Full Text] [Related]
6. Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype.
Tokar EJ; Diwan BA; Waalkes MP
Environ Health Perspect; 2010 Jan; 118(1):108-15. PubMed ID: 20056578
[TBL] [Abstract][Full Text] [Related]
7. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation.
Benbrahim-Tallaa L; Waterland RA; Styblo M; Achanzar WE; Webber MM; Waalkes MP
Toxicol Appl Pharmacol; 2005 Aug; 206(3):288-98. PubMed ID: 16039940
[TBL] [Abstract][Full Text] [Related]
8. Arsenite malignantly transforms human prostate epithelial cells in vitro by gene amplification of mutated KRAS.
Merrick BA; Phadke DP; Bostrom MA; Shah RR; Wright GM; Wang X; Gordon O; Pelch KE; Auerbach SS; Paules RS; DeVito MJ; Waalkes MP; Tokar EJ
PLoS One; 2019; 14(4):e0215504. PubMed ID: 31009485
[TBL] [Abstract][Full Text] [Related]
9. Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration.
Ngalame NN; Makia NL; Waalkes MP; Tokar EJ
Toxicol Appl Pharmacol; 2016 Dec; 312():11-18. PubMed ID: 26721309
[TBL] [Abstract][Full Text] [Related]
10. Arsenic-specific stem cell selection during malignant transformation.
Tokar EJ; Qu W; Liu J; Liu W; Webber MM; Phang JM; Waalkes MP
J Natl Cancer Inst; 2010 May; 102(9):638-49. PubMed ID: 20339138
[TBL] [Abstract][Full Text] [Related]
11. Arsenic-transformed malignant prostate epithelia can convert noncontiguous normal stem cells into an oncogenic phenotype.
Xu Y; Tokar EJ; Sun Y; Waalkes MP
Environ Health Perspect; 2012 Jun; 120(6):865-71. PubMed ID: 22472196
[TBL] [Abstract][Full Text] [Related]
12. Chronic exposure of renal stem cells to inorganic arsenic induces a cancer phenotype.
Tokar EJ; Person RJ; Sun Y; Perantoni AO; Waalkes MP
Chem Res Toxicol; 2013 Jan; 26(1):96-105. PubMed ID: 23137061
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of normal stem cells to an oncogenic phenotype by noncontiguous carcinogen-transformed epithelia depends on the transforming carcinogen.
Xu Y; Tokar EJ; Person RJ; Orihuela RG; Ngalame NN; Waalkes MP
Environ Health Perspect; 2013 Aug; 121(8):944-50. PubMed ID: 23687063
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.
Benbrahim-Tallaa L; Webber MM; Waalkes MP
Environ Health Perspect; 2005 Sep; 113(9):1134-9. PubMed ID: 16140617
[TBL] [Abstract][Full Text] [Related]
15. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
16. Overabundance of putative cancer stem cells in human skin keratinocyte cells malignantly transformed by arsenic.
Sun Y; Tokar EJ; Waalkes MP
Toxicol Sci; 2012 Jan; 125(1):20-9. PubMed ID: 22011395
[TBL] [Abstract][Full Text] [Related]
17. Chronic inorganic arsenic exposure in vitro induces a cancer cell phenotype in human peripheral lung epithelial cells.
Person RJ; Ngalame NN; Makia NL; Bell MW; Waalkes MP; Tokar EJ
Toxicol Appl Pharmacol; 2015 Jul; 286(1):36-43. PubMed ID: 25804888
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells.
Benbrahim-Tallaa L; Webber MM; Waalkes MP
Environ Health Perspect; 2007 Feb; 115(2):243-7. PubMed ID: 17384772
[TBL] [Abstract][Full Text] [Related]
19. Targeting the K-Ras--JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation.
Okada M; Shibuya K; Sato A; Seino S; Suzuki S; Seino M; Kitanaka C
Oncotarget; 2014 Jul; 5(13):5100-12. PubMed ID: 24947996
[TBL] [Abstract][Full Text] [Related]
20. Neoplastic transformation of human small airway epithelial cells induced by arsenic.
Wen G; Calaf GM; Partridge MA; Echiburú-Chau C; Zhao Y; Huang S; Chai Y; Li B; Hu B; Hei TK
Mol Med; 2008; 14(1-2):2-10. PubMed ID: 18037969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
